Momenta Pharmaceuticals, Inc. (MNTA)

[jmkobers]

Dew:

Based on these numbers, and despite the growing thrice weekly subscription rate (all of which is unlikely to hold upon the introduction of a generic), even if MYL and MNTA were to get simultaneous approval, how would MNTA not be profitable?

What am I missing? Seems to be plenty of meat left on that bone